TY  - JOUR
AU  - Gudiol, Carlota
AU  - Royo-Cebrecos, Cristina
AU  - Abdala, Edson
AU  - Akova, Murat
AU  - Alvarez, Rocio
AU  - Maestro-de la Calle, Guillermo
AU  - Cano, Angela
AU  - Cervera, Carlos
AU  - Clemente, Wanessa T.
AU  - Martin-Davila, Pilar
AU  - Freifeld, Alison
AU  - Gomez, Lucia
AU  - Gottlieb, Thomas
AU  - Gurgui, Merce
AU  - Herrera, Fabian
AU  - Manzur, Adriana
AU  - Maschmeyer, Georg
AU  - Meije, Yolanda
AU  - Montejo, Miguel
AU  - Peghin, Maddalena
AU  - Rodriguez-Bano, Jesus
AU  - Ruiz-Camps, Isabel
AU  - Sukiennik, Teresa C.
AU  - Tebe, Cristian
AU  - Carratala, Jordi
PY  - 2017
DO  - 10.1128/AAC.00164-17
SN  - 0066-4804
UR  - http://hdl.handle.net/10668/18998
T2  - Antimicrobial agents and chemotherapy
AB  - beta-Lactam/beta-lactamase inhibitors (BLBLIs) were compared to carbapenems in two cohorts of hematological neutropenic patients with extended-spectrum beta-lactamase (ESBL) bloodstream infection (BSI): the empirical therapy cohort (174 patients) and...
LA  - en
PB  - American Society for Microbiology
KW  - ESBLs
KW  - Bloodstream infection
KW  - Neutropenia
KW  - Beta-lactam/beta-lactamase inhibitors
KW  - Mortality
KW  - Escherichia-coli
KW  - Klebsiella-pneumoniae
KW  - Piperacillin-tazobactam
KW  - Risk-factors
KW  - Bacteremia
KW  - Carbapenems
KW  - Therapy
KW  - Mortality
KW  - Outcomes
KW  - Cancer
TI  - Efficacy of beta-Lactam/beta-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia
TY  - research article
VL  - 61
ER  -